Showing 341 - 360 results of 56,800 for search '(( 50 ((((mean decrease) OR (we decrease))) OR (a decrease)) ) OR ( i mean decrease ))', query time: 1.18s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344

    Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

    Published 2016
    “…Knockdown of C9orf72 significantly decreased p-S6K1 levels compared with cells treated with control shRNA (n = 3, *<i>p</i><0.5). …”
  5. 345
  6. 346

    Down-regulation of Gli decreased ovarian cancer cell migration and invasion. by Qi Chen (144168)

    Published 2014
    “…The data are expressed as mean ± SD for experiments performed three times. **, <i>P<</i>0.01, compared with control groups.…”
  7. 347
  8. 348

    Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

    Published 2010
    “…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356
  17. 357
  18. 358

    SUI-sEVs decreased the migration ability of primary cultured fibroblasts. by Xiaoyan Sun (28501)

    Published 2021
    “…N = 3 in each group. Data represented means±SD of 3 independent experiments. * t-test <i>P</i> value <0.05.…”
  19. 359

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”
  20. 360